Related Experiment Videos
Myocardial substrate metabolism: implications for diabetic cardiomyopathy
B Rodrigues1, M C Cam, J H McNeill
1Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Journal of Molecular and Cellular Cardiology
|January 1, 1995
Summary
Diabetic patients face higher cardiovascular mortality due to metabolic heart dysfunction. Early therapies targeting cardiac metabolism can prevent long-term heart damage and improve outcomes.
Area of Science:
- Cardiology
- Metabolic Disorders
- Biochemistry
Background:
- Diabetic patients exhibit increased cardiovascular disease (CVD) mortality.
- Both atherosclerotic CVD and intrinsic myocardial dysfunction contribute to diabetic cardiac morbidity and mortality.
Purpose of the Study:
- To investigate the sequence of metabolic events leading to cardiac dysfunction in diabetes.
- To identify early-stage therapeutic targets for preventing diabetic heart disease.
Main Methods:
- The study postulates a sequence of metabolic derangements in the diabetic heart.
- Focuses on myocardial carbohydrate and lipid metabolism abnormalities.
- Examines the role of insulin deficiency, metabolic intermediates, and calcium homeostasis disturbances.
Main Results:
- Insulin deficiency causes major abnormalities in myocardial carbohydrate and lipid metabolism.
- Accumulation of metabolic intermediates disrupts calcium homeostasis and alters subcellular membrane function.
- Chronic changes include reduced enzyme activity (myosin ATPase, Na(+)-K+ ATPase, Ca(2+)-ATPase) leading to cardiac dysfunction.
Conclusions:
- Early-stage metabolic disturbances in the diabetic heart are critical.
- Therapies targeting these early metabolic aberrations can prevent progressive cardiac damage.
- Lowering plasma triglycerides and free fatty acids (FFA) is crucial to reduce cardiac reliance on fatty acids and improve glucose utilization.